Vital-Imi
  • HOME
  • ABOUT
    • PARTNERS
    • WORK PACKAGES
      • Work Package 1
      • Work Package 2
      • Work Package 3
      • Work Package 4
      • Work Package 5
  • PUBLICATIONS
  • UPDATES
  • MENU
    • EVENTS
    • PARTNERS
    • NEWSLETTER
    • CONTACT
    • PRIVACY POLICY
    • LOGIN
  • Search
  • Menu Menu

Archive for: Publications

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program

Health Economics of Vaccines: From Current Practice to Future Perspectives

Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands

Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach

Preventing Infectious Diseases for Healthy Ageing: The VITAL Public-Private Partnership Project

Characteristics of Effective Educational Interventions Targeting Healthcare Workers to Improve Advising about Vaccinations for Adults of 50 Years and Older

Short- and Long-term Impact of Vaccination against Cytomegalovirus: a Modeling Study

Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives

Exploratory Analasys of the Economically Justifiable Price of an RSV Vaccine for the Elderly in the Netherland and United Kingdom

Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review)

Page 2 of 3123

Pages

  • About – page
  • Events
  • Home
  • Homepage
  • Join Us
  • Member Area
  • Member Login
  • MENU
  • NEWSLETTER
  • Partners
  • Partners – page
  • Password Reset
  • Privacy Policy
  • Profile
  • PUBLICATIONS
  • Publications – page
  • Registration
  • Test Page
  • Updates
  • UPDATES – page
  • Work Package 1
  • Work Package 1 – member area
  • Work Package 2
  • Work Package 2 – member area
  • Work Package 3
  • Work Package 3 – member area
  • Work Package 4
  • Work Package 4 – member area
  • Work Package 5
  • Work Package 5 – member area

Categories

  • No categories

Archive

    Contact

    You can contact us by sending us an email.

    The VITAL project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806776. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

    Scroll to top
    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok